Developer docs
API playgroundTry for free, no card

Search company profiles

Envista

Full company profile

uuid0002e6a

Namestring
Envista
Legal namestring
Envista Holdings Corporation
Websiteurl
envistaco.com
Company typeenum
Public
Founded yearint
2019
Descriptiontext

Envista Holdings Corporation (NYSE: NVST) is a Brea, California-headquartered global dental products company operating a portfolio of more than 30 trusted brands, including Nobel Biocare, Ormco, Spark, Implant Direct, Alpha Bio, DEXIS, Kerr Dental, Metrex, Orascoptic, and DTX Studio. The company was spun off from Danaher Corporation in 2019 and reports through two segments: Specialty Products & Technologies (dental implant systems, prosthetics, clear aligners, brackets and wires, and lab products) and Equipment & Consumables (digital imaging, dental practice equipment, endodontic systems, restorative materials, bonding agents, cements, and infection prevention). Underlying technology spans implant fixtures and prosthetics (Nobel Biocare, Implant Direct, Alpha Bio), orthodontic systems (Ormco brackets and wires; Spark clear aligners), digital imaging hardware (DEXIS intraoral sensors, panoramic and CBCT), and the DTX Studio software platform for treatment planning and digital workflow integration.

Envista generates revenue primarily through hardware and consumable product sales to dental professionals, dental service organizations (DSOs), and dental laboratories across more than 30 countries in the Americas, Europe, Asia Pacific, and the Middle East and Africa. The go-to-market combines direct enterprise sales for large DSOs, brand-specific e-commerce sites for smaller practices, and a network of dental equipment distributors and dealers. Pricing is not publicly disclosed and is negotiated through distribution channels. The company generated $2.72 billion in full-year 2025 revenue with 6.5% core growth, $372 million in adjusted EBITDA, and Q1 2026 revenue of $706 million (14.4% reported, 9.5% core growth) with adjusted EBITDA of $99 million; management has authorized up to $300 million in share repurchases. The company employs more than 10,000 people and is led by CEO Paul Keel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersBrea, United States
HQ citystring
Brea
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dental implant systems, orthodontic products, clear aligner systems, dental imaging equipment, dental consumables
Industry4 codes
PRIMARYHLAHAEAE
Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLABAJAD
Orthodontic Appliances & Aligners Fabrication
Healthcare & Life Sciences/Dental Care Services/Dental Laboratories & Prosthetic Fabrication
SECONDARYHLABAJAJ
Model/Die Work, Scanning & Case Digitization Services
Healthcare & Life Sciences/Dental Care Services/Dental Laboratories & Prosthetic Fabrication
SECONDARYCRABAFAH
Orthodontic & Aligner Care (Cleaners, Cases, Wax)
NAICS code3 codes
  • Dental Equipment and Supplies Manufacturing339114
  • Dental Laboratories339116
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code3 codes
  • Dental Equipment & Supplies3843
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Dental Products and Equipment
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Specialty Products & Technologies
TypeHardware Sales
Description

Dental implant systems, prosthetics, clear aligners (Spark), orthodontic brackets and wires, and lab products. This segment represents the company's higher-margin specialty business.

prnewswire.com
2Equipment & Consumables
TypeHardware Sales
Description

Digital imaging systems (Dexis), dental practice equipment, endodontic systems, restorative and impression materials, bonding agents, cements, and infection prevention products.

prnewswire.com
3Product Sales (Combined)
TypeHardware Sales
Description

Full year 2025 revenue of $2.72 billion with 6.5% core revenue growth. Q1 2026 revenue of $706 million up 14.4% year-over-year with adjusted EBITDA of $99 million (25% growth).

prnewswire.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1Nobel Biocare
Description

Dental implant systems and prosthetics

envistaco.com
+10 more records
Core offering1 text field

Envista develops, manufactures, and sells dental products and equipment through more than 30 brands, organized into Specialty Products & Technologies (dental implants, prosthetics, clear aligners, orthodontic brackets and wires, lab products) and Equipment & Consumables (digital imaging systems, dental practice equipment, restorative materials, bonding agents, infection prevention). The company's portfolio spans the full clinical workflow from diagnosis and imaging through treatment planning, surgical intervention, orthodontics, and restorative procedures, integrated by its DTX Studio digital workflow platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 14.4% year-over-year revenue growth in Q1 2026 to $706 million
+3 more records
Product overview1 text field

Envista is a global dental products company operating as a portfolio of more than 30 trusted dental brands organized into two main segments. The Specialty Products & Technologies division encompasses dental implant systems (Nobel Biocare, Implant Direct, Alpha Bio), orthodontic products (Ormco, Spark Clear Aligner), and surgical instruments (Orascoptic). The Equipment & Consumables segment includes digital imaging solutions (DEXIS), dental practice equipment and restorative materials (Kerr Dental), infection prevention products (Metrex), and digital workflow software (DTX Studio). The company's value proposition centers on integrated digital workflows that connect consultation, imaging, treatment planning, and clinical execution across its brand portfolio.

Product and service11 records
1Nobel Biocare Dental Implant Systems
CategoryDental Implants
Description

Dental implant systems and prosthetics manufacturer providing implant fixtures, prosthetic components, and surgical guides for tooth replacement procedures. Target customers are dental implantologists, periodontists, oral surgeons, and dental service organizations performing implant procedures.

2Ormco Orthodontic Products
CategoryOrthodontics
Description

Orthodontic bracket and wire systems for traditional and advanced orthodontic treatment. Used by orthodontists and dental professionals for teeth alignment procedures.

3Spark Clear Aligner System
CategoryClear Aligners
Description

Clear aligner system for orthodontic treatment offering an aesthetic alternative to traditional braces. Used by orthodontists and dental practitioners for teeth straightening procedures.

4Implant Direct Dental Implant Systems
CategoryDental Implants
Description

Cost-effective dental implant systems and surgical instruments for dental professionals performing implant procedures.

5Alpha Bio Dental Implant Systems
CategoryDental Implants
Description

Range of dental implant solutions for various clinical indications and treatment protocols, serving dental professionals performing implant procedures.

6DEXIS Digital Imaging Systems
CategoryDental Imaging
Description

Digital dental imaging systems including intraoral sensors, panoramic imaging, and CBCT systems for diagnostic and treatment planning purposes. Used by dental practices for comprehensive diagnostic capabilities.

7Kerr Dental Equipment and Restorative Materials
CategoryDental Equipment and Consumables
Description

Dental practice equipment and restorative materials including bonding agents, cements, restorative and impression materials for dental procedures. Used by general dentists and dental specialists.

8Demi Pro Cordless Curing Light
CategoryDental Equipment
Description

Cordless dental curing light with ergonomic design, 360-degree rotatable tip, optimized beam collimation, integrated safety features including internal radiometer and tip-mismatch detection for restorative dental procedures. Used by dental practitioners performing restorative work.

9Metrex Infection Prevention Products
CategoryInfection Prevention
Description

Infection prevention products and solutions for dental practices, ensuring compliance with hygiene and safety standards. Used by dental practices for sterilization and infection control.

10DTX Studio Digital Dentistry Software
CategoryDental Software
Description

Digital dentistry software platform enabling digital workflow management, imaging, and treatment planning for dental professionals. Used by dentists, orthodontists, and dental labs for integrated digital workflows.

11Orascoptic Surgical Loupes and Headlights
CategoryDental Equipment
Description

Surgical loupes and headlights providing magnification and illumination solutions for enhanced clinical precision. Used by dental professionals performing detailed clinical procedures.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-21
Description

Henry Schein, the Fortune 500 dental and medical supplies company, elected William K. 'Dan' Daniel as Independent Chairman. Daniel previously served on Envista's board when it was spun off from Danaher. The companies maintain ongoing supplier and distribution relationships in the dental market.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-07
Description

Envista completed the acquisition of Versah to expand its implant preparation technology portfolio. This acquisition strengthens Envista's dental implant offerings with Versah's proprietary drilling technology.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-04
Description

CooperCompanies appointed Envista CEO Paul Keel as an independent director to its Board, effective July 1, 2026. This board-level connection indicates a strategic relationship between the two medical device companies.

Strategic tierMinorTypeOthersAnnounced on2026-04-16
Description

Christine A. Tsingos, who serves on the board of Envista Holdings, was appointed to the board of Araceli Biosciences. This represents a board-level connection between the companies.

5Heartland Dental
Strategic tierCoreTypeGTM or Marketing Partner
Description

Heartland Dental, the nation's largest dental support organization with 1,900+ practices, partners with Envista for products and supplies. Envista participates in Heartland's Free Dentistry Day events providing donations and product support for community dental care initiatives.

prnewswire.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Align Technology (Invisalign/clear aligners) is identified as a major technology player alongside Envista in the cosmetic dentistry market transformation. Both companies compete in the clear aligner and digital orthodontics space.

7Dentsply Sirona
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dentsply Sirona is identified as a major competitor and technology driver alongside Envista in digital dentistry, CAD/CAM systems, and dental equipment markets.

thedailyhaze.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Dentsply Sirona
TypeDirect peer
Description

Dentsply Sirona is the most direct competitor to Envista, offering a similarly broad portfolio of dental equipment, imaging systems, CAD/CAM solutions, and specialty products including implants and orthodontics. Both companies target DSOs and specialty practices with comparable scale and digital workflow platforms.

TypeDirect peer
Description

Align Technology's Invisalign franchise is the dominant clear aligner system globally and competes head-to-head with Envista's Spark aligner system. Both companies serve orthodontists and general dentists through similar specialty channels with comparable digital workflow and case-planning technologies.

TypeDirect peer
Description

Straumann is the global leader in premium dental implants and a direct competitor to Envista's Nobel Biocare and Implant Direct brands. Both companies compete in the implant workflow ecosystem including surgical planning, abutments, and digital dentistry software.

TypeBroad incumbent
Description

Henry Schein is the largest dental distribution company and a major channel partner and competitor of Envista. Beyond distribution, Henry Schein offers its own dental technology, software, and practice solutions that overlap with Envista's Equipment & Consumables portfolio.

5Patterson Companies
TypeBroad incumbent
Description

Patterson is a leading North American dental and animal health distributor with a sizable dental equipment and consumables business that competes with Envista's Equipment & Consumables segment. Its direct sales force to dental practices overlaps substantially with Envista's distribution model.

TypeBroad incumbent
Description

3M's dental solutions division historically competed across restoratives, orthodontics, and preventive products before divestiture. Envista competes with 3M's remaining dental products and the post-divestiture Solventum entity across multiple product lines.

TypeDirect peer
Description

Ivoclar Vivadent is a privately held dental products manufacturer specializing in restorative materials, prosthetics, and digital equipment. It directly competes with Envista's Kerr brand in restorative consumables and with Envista's CAD/CAM and imaging offerings.

TypeEmerging player
Description

Solventum was spun off from 3M in 2024 and includes the dental and orthodontic products business that historically competed with Envista. It is an emerging standalone player in dental and orthodontic solutions and represents a focused competitor to Envista's Ormco orthodontic franchise.

TypeEmerging player
Description

ZimVie was spun off from Zimmer Biomet and focuses on dental implants and spine. Its dental implant portfolio directly competes with Envista's Nobel Biocare, Implant Direct, and Alpha Bio brands in the value and mid-tier implant segments.

TypeOthers
Description

Carestream Dental's intraoral scanning technology was acquired by Envista in 2021, but Carestream's remaining health imaging business remains adjacent. As a former supplier and now acquisition target, Carestream provides insight into the imaging workflow category where Envista's Dexis brand competes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries12 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Envista

Dental Products and Equipmentenvistaco.com

What Envista does

Envista Holdings Corporation (NYSE: NVST) is a Brea, California-headquartered global dental products company operating a portfolio of more than 30 trusted brands, including Nobel Biocare, Ormco, Spark, Implant Direct, Alpha Bio, DEXIS, Kerr Dental, Metrex, Orascoptic, and DTX Studio. The company was spun off from Danaher Corporation in 2019 and reports through two segments: Specialty Products & Technologies (dental implant systems, prosthetics, clear aligners, brackets and wires, and lab products) and Equipment & Consumables (digital imaging, dental practice equipment, endodontic systems, restorative materials, bonding agents, cements, and infection prevention). Underlying technology spans implant fixtures and prosthetics (Nobel Biocare, Implant Direct, Alpha Bio), orthodontic systems (Ormco brackets and wires; Spark clear aligners), digital imaging hardware (DEXIS intraoral sensors, panoramic and CBCT), and the DTX Studio software platform for treatment planning and digital workflow integration.

Envista generates revenue primarily through hardware and consumable product sales to dental professionals, dental service organizations (DSOs), and dental laboratories across more than 30 countries in the Americas, Europe, Asia Pacific, and the Middle East and Africa. The go-to-market combines direct enterprise sales for large DSOs, brand-specific e-commerce sites for smaller practices, and a network of dental equipment distributors and dealers. Pricing is not publicly disclosed and is negotiated through distribution channels. The company generated $2.72 billion in full-year 2025 revenue with 6.5% core growth, $372 million in adjusted EBITDA, and Q1 2026 revenue of $706 million (14.4% reported, 9.5% core growth) with adjusted EBITDA of $99 million; management has authorized up to $300 million in share repurchases. The company employs more than 10,000 people and is led by CEO Paul Keel.

Envista firmographics

Firmographics
Name
Envista
Legal name
Envista Holdings Corporation
Website
https://envistaco.com
Company type
Public
Founded year
2019
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Envista industry classification

Industry
Product category
Dental Products and Equipment
NAICS
Dental Equipment and Supplies Manufacturing (339114), Dental Laboratories (339116), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
Dental Equipment & Supplies (3843), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAEAE
Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLABAJAD
Orthodontic Appliances & Aligners Fabrication
Healthcare & Life Sciences/Dental Care Services/Dental Laboratories & Prosthetic Fabrication
SECONDARYHLABAJAJ
Model/Die Work, Scanning & Case Digitization Services
Healthcare & Life Sciences/Dental Care Services/Dental Laboratories & Prosthetic Fabrication
SECONDARYCRABAFAH
Orthodontic & Aligner Care (Cleaners, Cases, Wax)

Keywords

  • Dental implant systems
  • Orthodontic products
  • Clear aligner systems
  • Dental imaging equipment
  • Dental consumables

Where Envista is headquartered

Location

Headquarters

HQ city
Brea
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Envista business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Specialty Products & Technologies: Dental implant systems, prosthetics, clear aligners (Spark), orthodontic brackets and wires, and lab products. This segment represents the company's higher-margin specialty business.
  2. Equipment & Consumables: Digital imaging systems (Dexis), dental practice equipment, endodontic systems, restorative and impression materials, bonding agents, cements, and infection prevention products.
  3. Product Sales (Combined): Full year 2025 revenue of $2.72 billion with 6.5% core revenue growth. Q1 2026 revenue of $706 million up 14.4% year-over-year with adjusted EBITDA of $99 million (25% growth).

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Envista product offering

Product offering

Core offering

Envista develops, manufactures, and sells dental products and equipment through more than 30 brands, organized into Specialty Products & Technologies (dental implants, prosthetics, clear aligners, orthodontic brackets and wires, lab products) and Equipment & Consumables (digital imaging systems, dental practice equipment, restorative materials, bonding agents, infection prevention). The company's portfolio spans the full clinical workflow from diagnosis and imaging through treatment planning, surgical intervention, orthodontics, and restorative procedures, integrated by its DTX Studio digital workflow platform.

Product overview

Envista is a global dental products company operating as a portfolio of more than 30 trusted dental brands organized into two main segments. The Specialty Products & Technologies division encompasses dental implant systems (Nobel Biocare, Implant Direct, Alpha Bio), orthodontic products (Ormco, Spark Clear Aligner), and surgical instruments (Orascoptic). The Equipment & Consumables segment includes digital imaging solutions (DEXIS), dental practice equipment and restorative materials (Kerr Dental), infection prevention products (Metrex), and digital workflow software (DTX Studio). The company's value proposition centers on integrated digital workflows that connect consultation, imaging, treatment planning, and clinical execution across its brand portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • Nobel Biocare: Dental implant systems and prosthetics
  • Ormco
  • Spark
  • Implant Direct
  • DEXIS
  • Kerr
  • Metrex
  • DTX Studio
  • Orascoptic
  • Alpha Bio
  • Kerr Dental

Products and services

  • Nobel Biocare Dental Implant Systems Dental implant systems and prosthetics manufacturer providing implant fixtures, prosthetic components, and surgical guides for tooth replacement procedures. Target customers are dental implantologists, periodontists, oral surgeons, and dental service organizations performing implant procedures.
  • Ormco Orthodontic Products Orthodontic bracket and wire systems for traditional and advanced orthodontic treatment. Used by orthodontists and dental professionals for teeth alignment procedures.
  • Spark Clear Aligner System Clear aligner system for orthodontic treatment offering an aesthetic alternative to traditional braces. Used by orthodontists and dental practitioners for teeth straightening procedures.
  • Implant Direct Dental Implant Systems Cost-effective dental implant systems and surgical instruments for dental professionals performing implant procedures.
  • Alpha Bio Dental Implant Systems Range of dental implant solutions for various clinical indications and treatment protocols, serving dental professionals performing implant procedures.
  • DEXIS Digital Imaging Systems Digital dental imaging systems including intraoral sensors, panoramic imaging, and CBCT systems for diagnostic and treatment planning purposes. Used by dental practices for comprehensive diagnostic capabilities.
  • Kerr Dental Equipment and Restorative Materials Dental practice equipment and restorative materials including bonding agents, cements, restorative and impression materials for dental procedures. Used by general dentists and dental specialists.
  • Demi Pro Cordless Curing Light Cordless dental curing light with ergonomic design, 360-degree rotatable tip, optimized beam collimation, integrated safety features including internal radiometer and tip-mismatch detection for restorative dental procedures. Used by dental practitioners performing restorative work.
  • Metrex Infection Prevention Products Infection prevention products and solutions for dental practices, ensuring compliance with hygiene and safety standards. Used by dental practices for sterilization and infection control.
  • DTX Studio Digital Dentistry Software Digital dentistry software platform enabling digital workflow management, imaging, and treatment planning for dental professionals. Used by dentists, orthodontists, and dental labs for integrated digital workflows.
  • Orascoptic Surgical Loupes and Headlights Surgical loupes and headlights providing magnification and illumination solutions for enhanced clinical precision. Used by dental professionals performing detailed clinical procedures.

Quantifiable outcome

  • 14.4% year-over-year revenue growth in Q1 2026 to $706 million
  • +3 more outcomes

Companies that use Envista

Customer profile

Segments3 records

Ideal customer profiles3 records

Envista technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Envista partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Henry ScheincoreStrategic or Co-development Partner · 21 May 2026Henry Schein, the Fortune 500 dental and medical supplies company, elected William K. 'Dan' Daniel as Independent Chairman. Daniel previously served on Envista's board when it was spun off from Danaher. The companies maintain ongoing supplier and distribution relationships in the dental market.
  • VersahminorStrategic or Co-development Partner · 7 May 2026Envista completed the acquisition of Versah to expand its implant preparation technology portfolio. This acquisition strengthens Envista's dental implant offerings with Versah's proprietary drilling technology.
  • CooperCompaniesminorStrategic or Co-development Partner · 4 May 2026CooperCompanies appointed Envista CEO Paul Keel as an independent director to its Board, effective July 1, 2026. This board-level connection indicates a strategic relationship between the two medical device companies.
  • Araceli BiosciencesminorOthers · 16 April 2026Christine A. Tsingos, who serves on the board of Envista Holdings, was appointed to the board of Araceli Biosciences. This represents a board-level connection between the companies.
  • Heartland DentalcoreGTM or Marketing PartnerHeartland Dental, the nation's largest dental support organization with 1,900+ practices, partners with Envista for products and supplies. Envista participates in Heartland's Free Dentistry Day events providing donations and product support for community dental care initiatives.
  • Align TechnologycoreStrategic or Co-development PartnerAlign Technology (Invisalign/clear aligners) is identified as a major technology player alongside Envista in the cosmetic dentistry market transformation. Both companies compete in the clear aligner and digital orthodontics space.
  • Dentsply SironacoreStrategic or Co-development PartnerDentsply Sirona is identified as a major competitor and technology driver alongside Envista in digital dentistry, CAD/CAM systems, and dental equipment markets.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Envista competitors and assessment

Company assessment

Direct peers

  • Dentsply Sirona: Dentsply Sirona is the most direct competitor to Envista, offering a similarly broad portfolio of dental equipment, imaging systems, CAD/CAM solutions, and specialty products including implants and orthodontics. Both companies target DSOs and specialty practices with comparable scale and digital workflow platforms.
  • Align Technology: Align Technology's Invisalign franchise is the dominant clear aligner system globally and competes head-to-head with Envista's Spark aligner system. Both companies serve orthodontists and general dentists through similar specialty channels with comparable digital workflow and case-planning technologies.
  • Straumann Group: Straumann is the global leader in premium dental implants and a direct competitor to Envista's Nobel Biocare and Implant Direct brands. Both companies compete in the implant workflow ecosystem including surgical planning, abutments, and digital dentistry software.
  • Ivoclar Vivadent: Ivoclar Vivadent is a privately held dental products manufacturer specializing in restorative materials, prosthetics, and digital equipment. It directly competes with Envista's Kerr brand in restorative consumables and with Envista's CAD/CAM and imaging offerings.

Broad incumbents

  • Henry Schein: Henry Schein is the largest dental distribution company and a major channel partner and competitor of Envista. Beyond distribution, Henry Schein offers its own dental technology, software, and practice solutions that overlap with Envista's Equipment & Consumables portfolio.
  • Patterson Companies: Patterson is a leading North American dental and animal health distributor with a sizable dental equipment and consumables business that competes with Envista's Equipment & Consumables segment. Its direct sales force to dental practices overlaps substantially with Envista's distribution model.
  • 3M (Dental Solutions): 3M's dental solutions division historically competed across restoratives, orthodontics, and preventive products before divestiture. Envista competes with 3M's remaining dental products and the post-divestiture Solventum entity across multiple product lines.

Emerging players

  • Solventum (formerly 3M Health Care): Solventum was spun off from 3M in 2024 and includes the dental and orthodontic products business that historically competed with Envista. It is an emerging standalone player in dental and orthodontic solutions and represents a focused competitor to Envista's Ormco orthodontic franchise.
  • ZimVie: ZimVie was spun off from Zimmer Biomet and focuses on dental implants and spine. Its dental implant portfolio directly competes with Envista's Nobel Biocare, Implant Direct, and Alpha Bio brands in the value and mid-tier implant segments.

Others

  • Carestream Health (Dental): Carestream Dental's intraoral scanning technology was acquired by Envista in 2021, but Carestream's remaining health imaging business remains adjacent. As a former supplier and now acquisition target, Carestream provides insight into the imaging workflow category where Envista's Dexis brand competes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Envista social profiles

Digital presence

Envista financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Envista leadership team

Management profile

Number of profiles

Profiles9 records

Envista subsidiaries and ownership

Company hierarchy

Subsidiaries12 records

Envista funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Envista M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Envista

What does Envista do?

Envista develops, manufactures, and sells dental products and equipment through more than 30 brands, organized into Specialty Products & Technologies (dental implants, prosthetics, clear aligners, orthodontic brackets and wires, lab products) and Equipment & Consumables (digital imaging systems, dental practice equipment, restorative materials, bonding agents, infection prevention). The company's portfolio spans the full clinical workflow from diagnosis and imaging through treatment planning, surgical intervention, orthodontics, and restorative procedures, integrated by its DTX Studio digital workflow platform.

Is Envista a public or private company?

Envista is a public company. It is classified as public and is currently operating.

When was Envista founded?

Envista was founded in 2019. It employs 1,001 to 5,000 people.

Where is Envista based?

Envista is headquartered in Brea, United States, in the North America region.

How does Envista make money?

Three revenue lines are on record. Specialty Products & Technologies are the primary driver. The others are equipment & Consumables and product Sales (Combined).

Who are Envista's main competitors?

Direct peers on record are Dentsply Sirona, Align Technology, Straumann Group and Ivoclar Vivadent. Broad incumbents are Henry Schein, Patterson Companies and 3M (Dental Solutions). Emerging players are Solventum (formerly 3M Health Care) and ZimVie. Carestream Health (Dental) is listed as an others.

Does Envista have an API?

No public API is recorded for Envista.

What industry is Envista in?

Envista's product category is Dental Products and Equipment. Its primary akta.pro industry code is HLAHAEAE, Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics), with a secondary code of HLABAJAD, Orthodontic Appliances & Aligners Fabrication. Its NAICS code is 339114 and its SIC code is 3843.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comEnvista prices $430 million senior notes offering due 2033Envista Holdings priced $430 million in 6.25% senior notes due 2033 at 99.482% of principal, with closing expected November 24, 2026. Proceeds will repay U.S. dollar term loan A and general corporate purposes.PR NewswireEnvista Announces Pricing of $430 Million of Senior NotesEnvista Holdings priced $430 million in 6.250% senior notes due 2033 at 99.482% of principal, with closing expected November 24, 2026. Proceeds will repay U.S. dollar term loan A and pay related fees, plus general corporate purposes.Stock TitanEnvista prices $430M senior notes due 2033Envista Holdings priced $430 million of 6.250% senior notes due 2033 at 99.482% of principal. The offering is expected to close on November 24, 2026, with proceeds used to repay term loan A and for general corporate purposes.MoomooEnvista Announces Pricing of $430 Million of Senior NotesEnvista Holdings priced $430 million in 6.250% senior notes due 2033 at 99.482% of principal, with closing expected November 24, 2026. Proceeds will repay U.S. dollar term loan A and pay related fees, plus general corporate purposes.Simply Wall StMissed Envista's Run? Here's What Early Buyers SawEnvista's Q3 2026 revenue rose to $691.5 million and net income to $508.3 million, reversing a prior loss. Net margin improved to 73.5%, supporting an optimistic profitability story. The stock trades at $25.97, with a bearish analyst fair value below that level.YahooVote for Shawnee County's Athlete of the Week presented by Envista | Football EditionThe Topeka Capital-Journal is voting for its Athlete of the Week, presented by Envista, with 17 football nominations. Last week's volleyball winner was Kinley Weber with 2,675 votes (85.7% of votes). The poll closes at noon on Tuesday, Nov. 17.American Banking and Market NewsEnvista (NYSE:NVST) Price Target Raised to $29.00UBS raised its price target on Envista to $29 from $27, keeping a neutral rating. The company reported Q3 adjusted EPS of $0.40 and revenue of $691.5 million, both above estimates, with revenue up 3.2% year over year. Management also lifted its earnings outlook citing pricing and productivity gains.Simply Wall StLearn Why The Bull Case For Envista Holdings Stock Could Change Following Earnings Guidance RaiseEnvista Holdings reported Q3 2026 sales of $691.5 million and net income of $508.3 million, a turnaround from a prior loss. It raised its 2026 adjusted EPS guidance to $1.54-$1.58, citing pricing, productivity, and digital product growth. China's volume-based procurement headwinds remain a key risk.Defense WorldEnvista (NYSE:NVST) Stock Price Target Raised at UBS GroupUBS raised its price target on Envista to $29 from $27, keeping a neutral rating. Envista reported Q3 EPS of $0.40, beating the $0.36 consensus, with revenue of $691.5 million, up 3.2% year over year. The company also raised its 2026 earnings outlook citing pricing and productivity gains.TradingViewUBS maintains Envista Holdings at Neutral, raises price target to $29 from $27UBS maintained Envista Holdings at Neutral and raised its price target to $29 from $27, a 7.4% increase. The target implies a 16.2% upside from the Nov 5 close of $24.96. Recent analyst price targets range from $26 to $32.